EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference
Rhea-AI Summary
EDAP (Nasdaq: EDAP) announced that CEO Ryan Rhodes and CFO Ken Mobeck will present at the Jefferies 2026 Global Healthcare Conference in New York.
The presentation and 1x1 investor meetings are scheduled for Thursday, June 4, 2026, from 2:00–2:30 PM ET, with a live and archived webcast available via the Investors section of the company website.
Positive
- None.
Negative
- None.
News Market Reaction – EDAP
In the May 21 session, EDAP gained 1.88%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 14 | Collaboration announcement | Positive | -0.7% | Non-binding LOI with Telix for joint HIFU and PSMA PET initiatives. |
| May 13 | Investor event | Positive | -0.7% | Announcement of June 1 Investor Day focused on growth strategy and targets. |
| May 07 | Earnings release | Positive | +15.7% | Record Q1 2026 HIFU revenue and strong system sales growth. |
| Apr 30 | Clinical data update | Positive | +0.3% | HIFI-2 salvage HIFU data with favorable ADT-free survival and safety. |
| Apr 16 | Earnings date notice | Neutral | +2.0% | Scheduling announcement for Q1 2026 results call and webcast. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Positive operational and clinical news often produced modest moves, while strong earnings updates coincided with a more pronounced positive reaction.
Over recent months, EDAP reported multiple positive developments, including record Q1 2026 HIFU revenue of $11.6M within total revenue of $17.8M and favorable HIFI-2 prostate cancer data involving 531 patients across >30 centers. Earnings news on May 7 drove a 15.72% gain, while other constructive items—such as the Telix collaboration and the June 1 Investor Day announcement—saw small negative or muted price moves. Today’s conference participation fits the pattern of ongoing visibility-building rather than a major financial catalyst.
AI-generated analysis. How Rhea-AI works. Not financial advice.
, May 21, 2026 (GLOBE NEWSWIRE) -- EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference
Company to Present and Host 1x1 Investor Meetings on Thursday, June 4th, 2026
AUSTIN, Texas, May 21th, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present and, together with Ken Mobeck, Chief Financial Officer, will host 1x1 investor meetings at the upcoming Jefferies 2026 Global Healthcare Conference in New York.
Date: Thursday, June 4th
Time: 2:00-2:30 PM ET
Format: Presentation and 1x1 investor meetings
Webcast: https://event.summitcast.com/view/NgCqua4VVQjq9ibVWHVWca/mNTgvmem3UJgTk2XzExVDK
The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.
About EDAP TMS SA
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com/.
Investor Contact
Louisa Smith
Gilmartin Group
Investor.relations@focalone.com
